Academic Article RDF

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...

• ²¹²Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models
• ²⁷Al and ¹³C NMR Relaxation Studies of Aminoalanes
• ²H NMR demonstration of amino acid-nucleotide interactions
• ³¹P and ¹H NMR studies of the transesterification polymerization of polyphosphonate oligomers
• ³¹P chemical shift imaging of the regionally ischemic perfused heart
• ³¹P MRS measurement of mitochondrial function in skeletal muscle: Reliability, force-level sensitivity and relation to whole body maximal oxygen uptake
• ³¹P NMR 2D mapping of creatine kinase forward flux rate in hearts with postinfarction left ventricular remodeling in response to cell therapy
• ³¹P nmr and hplc investigations of the cyclophosphamide metabolite, phosphoramme mustard
• ³¹P NMR and X-ray crystallographic study of atropisomerism in cis-tetracarbonylmolybdenum(0) and cis-dichloroplatinum(II) complexes of (±)-6,6′-[[1,1′-Biphenyl]-2,2′-diylbis(oxy)] bis(dibenzo[d,f]-[1,3,2]dioxaphosphepin) and (±)-6,6′-[[1,1′-Binaphthyl]-2,2′-diylbis(oxy)] bis(dibenzo[d,f][1,3,2]dioxaphosphepin) ligands
• ³¹P NMR of mammalian cells encapsulated in alginate gels utilizing a new phosphate‐free perfusion medium
• ³¹P NMR spectroscopy in chronic adriamycin cardiotoxicity
• ³¹P NMR spectroscopy of in vivo tumors
• ³¹P(¹H) NMR studies of the preparation of dichlorotris(2,4,6-tribromophenoxy)phosphorane, trichlorobis(2,4,6-tribromophenoxy)phosphorane and tetrachloro(2,4,6-tribromophenoxy)phosphorane, and their nonoxidative chlorination reactions with dimethyl phosphonate
• ³¹P-magnetic resonance spectroscopy studies of cardiac transplant patients at rest
• ³¹P‐NMR DIFFERENTIATION BETWEEN INTRACELLULAR PHOSPHATE POOLS IN COSMARIUM (CHLOROPHYTA)
• ³¹P{¹H} NMR spectroscopic and X-ray crystallographic studies of conformational dynamics in cis-M{Ph2P(CH2CH2O)5CH2CH2PPh2-P,P'} (M = Mo(CO)4, PtCl2) metallacrown ethers
• ³¹P{¹H} NMR studies of the nonoxidative chlorination of poly(1,12-dodecane phosphonate) and subsequent coordination and nucleophilic reactions
• ³²P-postlabeling assay for the quantification of the major platinum- DNA adducts
• ⁵⁵Cobalt complexes with pendant carbohydrates as potential PET imaging agents
• ⁶⁴Cu-ATSM positron emission tomography/ magnetic resonance imaging of hypoxia in human atherosclerosis
• ⁶⁷Cu- versus ¹³¹I-labeled Lym-1 antibody: Comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma
• ⁶⁷Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma
• ⁶⁷Ga scintigraphy in HIV antibody positive patients; A review of its clinical usefulness
• ⁸⁹Zr-DFO-Cetuximab as a Molecular Imaging Agent to Identify Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma
• ⁸⁹Zr-radiolabeled trastuzumab imaging in orthotopic and metastatic breast tumors
• ^99mTc-MAG3: Image wisely
• ^99mTc-tilmanocept: A novel molecular agent for lymphatic mapping and sentinel lymph node localization
• [10] Purification of endothelial nitric oxide synthase
• [13] Generation of monoclonal antibodies to endothelial nitric oxide synthase
• [21] Antigen-Specific Factors: An Overview

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...